Episode 158: Rethinking Biotech Fundraising and Innovation in Women’s Healthcare

How can biotech entrepreneurs challenge traditional approaches to funding and drug development to bring much-needed innovations to patients?

In this episode, host Elaine Hamm, PhD, sits down with Sabrina Martucci Johnson, the Founder, President, and CEO of Daré Bioscience, to explore her journey building a company dedicated to addressing overlooked and underfunded needs in women's health. Sabrina shares how she identified opportunities in an underserved market, built a diverse portfolio of therapeutics, and developed innovative solutions. They discuss Daré's creative approach to fundraising, including how the publicly traded company created an opportunity for everyday investors to directly support its mission

In this episode, you'll discover:

How Daré Bioscience identifies gaps in women's healthcare and develops innovative therapies by combining patient needs with established science.

Why alternative fundraising strategies, including public investment offerings, can help biotech companies engage new investors and expand access to capital.

How creative thinking, strategic risk management, and a patient-focused mission can help entrepreneurs overcome barriers to developing and commercializing healthcare innovations.

Tune in to discover how challenging conventional approaches to biotech development and fundraising can create new opportunities for entrepreneurs while advancing much-needed solutions in women's health.

Links:

Connect with Sabrina Martucci Johnson and learn about Daré Bioscience.

Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.

Connect with Ian McLachlan, BIO from the BAYOU producer.

Learn more about BIO from the BAYOU - the podcast.